321 related articles for article (PubMed ID: 36830895)
21. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
Leong IT; Fernandes BJ; Mock D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus interactions with the Bcl-2 protein family and apoptosis in human tumor cells.
Fu Q; He C; Mao ZR
J Zhejiang Univ Sci B; 2013 Jan; 14(1):8-24. PubMed ID: 23303627
[TBL] [Abstract][Full Text] [Related]
23. Repression of the proapoptotic cellular BIK/NBK gene by Epstein-Barr virus antagonizes transforming growth factor β1-induced B-cell apoptosis.
Campion EM; Hakimjavadi R; Loughran ST; Phelan S; Smith SM; D'Souza BN; Tierney RJ; Bell AI; Cahill PA; Walls D
J Virol; 2014 May; 88(9):5001-13. PubMed ID: 24554662
[TBL] [Abstract][Full Text] [Related]
24. Reactivation of lytic replication from B cells latently infected with Epstein-Barr virus occurs with high S-phase cyclin-dependent kinase activity while inhibiting cellular DNA replication.
Kudoh A; Fujita M; Kiyono T; Kuzushima K; Sugaya Y; Izuta S; Nishiyama Y; Tsurumi T
J Virol; 2003 Jan; 77(2):851-61. PubMed ID: 12502801
[TBL] [Abstract][Full Text] [Related]
25. Glucocorticoids activate Epstein Barr virus lytic replication through the upregulation of immediate early BZLF1 gene expression.
Yang EV; Webster Marketon JI; Chen M; Lo KW; Kim SJ; Glaser R
Brain Behav Immun; 2010 Oct; 24(7):1089-96. PubMed ID: 20466055
[TBL] [Abstract][Full Text] [Related]
26. The signaling pathways of Epstein-Barr virus-encoded latent membrane protein 2A (LMP2A) in latency and cancer.
Pang MF; Lin KW; Peh SC
Cell Mol Biol Lett; 2009; 14(2):222-47. PubMed ID: 19082921
[TBL] [Abstract][Full Text] [Related]
27. Identifying the Cellular Interactome of Epstein-Barr Virus Lytic Regulator Zta Reveals Cellular Targets Contributing to Viral Replication.
Zhou Y; Heesom K; Osborn K; AlMohammed R; Sweet SM; Sinclair AJ
J Virol; 2020 Jan; 94(3):. PubMed ID: 31694936
[TBL] [Abstract][Full Text] [Related]
28. Multiple Viral microRNAs Regulate Interferon Release and Signaling Early during Infection with Epstein-Barr Virus.
Bouvet M; Voigt S; Tagawa T; Albanese M; Chen YA; Chen Y; Fachko DN; Pich D; Göbel C; Skalsky RL; Hammerschmidt W
mBio; 2021 Mar; 12(2):. PubMed ID: 33785626
[TBL] [Abstract][Full Text] [Related]
29. Latency and lytic replication in Epstein-Barr virus-associated oncogenesis.
Münz C
Nat Rev Microbiol; 2019 Nov; 17(11):691-700. PubMed ID: 31477887
[TBL] [Abstract][Full Text] [Related]
30. BGLF4 kinase modulates the structure and transport preference of the nuclear pore complex to facilitate nuclear import of Epstein-Barr virus lytic proteins.
Chang CW; Lee CP; Su MT; Tsai CH; Chen MR
J Virol; 2015 Feb; 89(3):1703-18. PubMed ID: 25410863
[TBL] [Abstract][Full Text] [Related]
31. Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters.
Reusch JA; Nawandar DM; Wright KL; Kenney SC; Mertz JE
J Virol; 2015 Feb; 89(3):1731-43. PubMed ID: 25410866
[TBL] [Abstract][Full Text] [Related]
32. ZEB1 regulates the latent-lytic switch in infection by Epstein-Barr virus.
Yu X; Wang Z; Mertz JE
PLoS Pathog; 2007 Dec; 3(12):e194. PubMed ID: 18085824
[TBL] [Abstract][Full Text] [Related]
33. Interplay between the Epigenetic Enzyme Lysine (K)-Specific Demethylase 2B and Epstein-Barr Virus Infection.
Vargas-Ayala RC; Jay A; Manara F; Maroui MA; Hernandez-Vargas H; Diederichs A; Robitaille A; Sirand C; Ceraolo MG; Romero-Medina MC; Cros MP; Cuenin C; Durand G; Le Calvez-Kelm F; Mundo L; Leoncini L; Manet E; Herceg Z; Gruffat H; Accardi R
J Virol; 2019 Jul; 93(13):. PubMed ID: 30996097
[TBL] [Abstract][Full Text] [Related]
34. Histone Loaders CAF1 and HIRA Restrict Epstein-Barr Virus B-Cell Lytic Reactivation.
Zhang Y; Jiang C; Trudeau SJ; Narita Y; Zhao B; Teng M; Guo R; Gewurz BE
mBio; 2020 Oct; 11(5):. PubMed ID: 33109754
[TBL] [Abstract][Full Text] [Related]
35. Dynamic Epstein-Barr virus gene expression on the path to B-cell transformation.
Price AM; Luftig MA
Adv Virus Res; 2014; 88():279-313. PubMed ID: 24373315
[TBL] [Abstract][Full Text] [Related]
36. Sumoylation of the Epstein-Barr virus BZLF1 protein inhibits its transcriptional activity and is regulated by the virus-encoded protein kinase.
Hagemeier SR; Dickerson SJ; Meng Q; Yu X; Mertz JE; Kenney SC
J Virol; 2010 May; 84(9):4383-94. PubMed ID: 20181712
[TBL] [Abstract][Full Text] [Related]
37. Latent Membrane Protein 1 Is a Novel Determinant of Epstein-Barr Virus Genome Persistence and Reactivation.
Caves EA; Butch RM; Cook SA; Wasil LR; Chen C; Di YP; Lee N; Shair KHY
mSphere; 2017; 2(6):. PubMed ID: 29134204
[TBL] [Abstract][Full Text] [Related]
38. Lytic cycle switches of oncogenic human gammaherpesviruses.
Miller G; El-Guindy A; Countryman J; Ye J; Gradoville L
Adv Cancer Res; 2007; 97():81-109. PubMed ID: 17419942
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr Virus (EBV) Tegument Protein BGLF2 Suppresses Type I Interferon Signaling To Promote EBV Reactivation.
Liu X; Sadaoka T; Krogmann T; Cohen JI
J Virol; 2020 May; 94(11):. PubMed ID: 32213613
[TBL] [Abstract][Full Text] [Related]
40. Retrograde Regulation by the Viral Protein Kinase Epigenetically Sustains the Epstein-Barr Virus Latency-to-Lytic Switch To Augment Virus Production.
Li X; Kozlov SV; El-Guindy A; Bhaduri-McIntosh S
J Virol; 2019 Sep; 93(17):. PubMed ID: 31189703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
